What is the price-to-earnings ratio of Progyny?
The price-earnings ratio of Progyny is currently 2.4.
Progyny P/S 2024
Progyny P/S
2.4
Ticker
PGNY
ISIN
US74340E1038
WKN
A2PT5Q
As of Dec 18, 2024, Progyny's P/S ratio stood at 2.4, a -31.43% change from the 3.5 P/S ratio recorded in the previous year.
The Progyny P/S history
Progyny Aktienanalyse
What does Progyny do?
Progyny Inc. is a company specializing in reproductive medicine and fertility treatments. It was founded in New York City in 2008 and has been listed on the NASDAQ stock exchange since 2019. The idea for Progyny arose when founder Gina Bartasi herself had difficulty getting pregnant and was searching for support and transparent information. She recognized the need to offer a better and more accessible service for people with fertility problems, thus founding Progyny. Progyny's business model is to offer employers a fertility benefit to help their employees, especially women, with family planning. It provides customized fertility treatments and financial assistance through its innovative programs. This allows employers to position themselves as progressive and inclusive while also increasing the bond and well-being of their employees. The different divisions of Progyny include fertility management, fertility measurement and monitoring, and fertility benefits. The fertility management solutions provide companies with comprehensive care for their employees, including counseling and support on fertility and family planning. They also provide access to an exclusive network practice specializing in reproductive medicine, including in vitro fertilization (IVF) and egg donation. The fertility measurement and monitoring program offers a personalized fertility profile that allows employees to track their fertility status to maximize their chances of a successful pregnancy. Progyny utilizes advanced methods of artificial intelligence and machine learning for this purpose. Progyny's fertility benefits include financial support for fertility treatments and medications that are not normally covered by health insurance. Additionally, the company offers a unique membership option that provides unlimited access to master fertility practices for one year. Progyny also offers a comprehensive patient experience through world-leading doctors and a patented technology platform. The platform provides support in navigating the fertility process and ensures that patients receive the best possible medical and financial care. Overall, Progyny has a significant impact on the field of reproductive medicine. With an innovative solution tailored to the needs of employers and strong support for aspiring parents, the company achieves a higher success rate in pregnancy compared to traditional fertility treatments. Progyny's technology platform improves workflow efficiency and communication in the practice, leading to a better patient experience and greater engagement. Overall, Progyny offers a holistic solution for employers and employees tailored to the unique challenges of family planning and fertility. With innovative approaches and a focus on the well-being of female employees, the company has taken a unique position in the market and is expected to continue to play a strong role in the industry. Progyny ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Progyny's P/S Ratio
Progyny's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Progyny's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Progyny's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Progyny’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Progyny stock
How has the price-earnings ratio of Progyny changed compared to last year?
The price-to-earnings ratio of Progyny has increased by -31.43% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Progyny high compared to other companies?
Yes, the price-to-earnings ratio of Progyny is high compared to other companies.
How does an increase in the price-earnings ratio of Progyny affect the company?
An increase in the price-earnings ratio of Progyny would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Progyny affect the company?
A decrease in the price-earnings ratio of Progyny would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Progyny?
Some factors that influence the price-earnings ratio of Progyny are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Progyny pay?
Over the past 12 months, Progyny paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Progyny is expected to pay a dividend of 0 USD.
What is the dividend yield of Progyny?
The current dividend yield of Progyny is .
When does Progyny pay dividends?
Progyny pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Progyny?
Progyny paid dividends every year for the past 0 years.
What is the dividend of Progyny?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Progyny located?
Progyny is assigned to the 'Health' sector.
Wann musste ich die Aktien von Progyny kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Progyny from 12/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.
When did Progyny pay the last dividend?
The last dividend was paid out on 12/18/2024.
What was the dividend of Progyny in the year 2023?
In the year 2023, Progyny distributed 0 USD as dividends.
In which currency does Progyny pay out the dividend?
The dividends of Progyny are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Progyny
Our stock analysis for Progyny Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Progyny Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
